| Gene symbol | HTR2A | Synonyms | 5-HT2A, HTR2 | Type of gene | protein-coding |
| Chromosome | 13 | Map location | 13q14.2 | dbXrefs | |
| Description | 5-hydroxytryptamine receptor 2A | ||||
| GTO ID | GTC3752 |
| Trial ID | NCT06251544 |
| Disease | Breast Cancer |
| Altered gene | HTR2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | HTR2 T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | (TRAILBLASER) TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor T Cells for the Treatment of Metastatic Breast Cancer |
| Year | 2024 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-54673 TRAILBLASER |
| Cohort 1 | |||||||||
|
|||||||||